The price of Cardiff Oncology Inc (NASDAQ: CRDF) closed at $5.39 in the last session, down -8.80% from day before closing price of $5.91. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 1445397 shares were traded.
Ratios:
We take a closer look at CRDF’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’23 when PACE GARY W bought 30,000 shares for $1.37 per share. The transaction valued at 41,100 led to the insider holds 697,761 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 241.26M and an Enterprise Value of 168.58M. For the stock, the TTM Price-to-Sale (P/S) ratio is 491.48 while its Price-to-Book (P/B) ratio in mrq is 3.45. Its current Enterprise Value per Revenue stands at 345.46 whereas that against EBITDA is -3.75.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is 2.72, while the 200-Day Moving Average is calculated to be 1.78.
Shares Statistics:
According to the various share statistics, CRDF traded on average about 1.59M shares per day over the past 3-months and 1.94M shares per day over the past 10 days. A total of 44.68M shares are outstanding, with a floating share count of 41.07M. Insiders hold about 8.07% of the company’s shares, while institutions hold 12.13% stake in the company. Shares short for CRDF as of Feb 29, 2024 were 1.15M with a Short Ratio of 0.73, compared to 1.29M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.59% and a Short% of Float of 2.66%.
Earnings Estimates
The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.25 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.27, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.24 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.8 and -$1.06 for the fiscal current year, implying an average EPS of -$0.97. EPS for the following year is -$1.05, with 3 analysts recommending between -$0.8 and -$1.19.
